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Background: Persistent wound drainage after total joint arthroplasty (TJA) is an important complication
with potential substantial adverse consequences, in particular periprosthetic joint infection.
Methods: This review evaluated the available literature regarding several issues in the ﬁeld of persistent
wound drainage after TJA and offers a classiﬁcation of persistent wound drainage and an algorithmic
approach to the decision-making process.
Results: Available literature addressing the diagnosis and treatment of persistent wound drainage after
TJA is scarce and an evidence-based clinical guideline is lacking. This is partially caused by the absence of
a universally accepted deﬁnition of persistent wound drainage. In patients with persistent wound
drainage, clinical signs and serological tests can be helpful in the diagnosis of a developing infection.
Regarding the treatment of persistent wound drainage, nonsurgical treatment consists of absorbent
dressings, pressure bandages, and temporary joint immobilization. Surgical treatment is advised when
wound drainage persists for more than 5-7 days and consists of open debridement with irrigation and
exchange of modular components and antimicrobial treatment.
Conclusion: Based on this literature review, we proposed a classiﬁcation and algorithmic approach for
the management of patients with persistent wound drainage after TJA. Hopefully, this offers the or-
thopedic surgeon a practical clinical guideline by ﬁnding the right balance between overtreatment and
undertreatment, weighing the risks and beneﬁts. However, this classiﬁcation and algorithmic approach
should ﬁrst be evaluated in a prospective trial.
© 2018 The Author(s). Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).closed potential or pertinent
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(TJA) is an important problem because of its potential adverse in-
outcome [1e4,7e9,12,24,27e32]. Mortazavi et al [31] found sub-
stantially worse patient satisfaction and lower Harris Hip Scores inﬂuence on the outcome following TJA, in particular development of
a periprosthetic joint infection (PJI) [1e8]. PJI is associated with
high morbidity and mortality, and a high socioeconomic burden
due to prolonged hospital stay, surgical procedure(s), antimicrobial
treatment, and wound care.
Remarkably, PWD is rarely reported in literature and thereby
literature fails to provide conclusive scientiﬁc evidence on many
issues related to PWD after TJA, including the deﬁnition and
treatment of PWD. This lack of evidence results in wide variation in
diagnosis and treatment in daily practice, often only founded by the
surgeon’s opinion. The absence of scientiﬁc consensus prompted
this review of the available literature.
We performed a literature search and included all papers rele-
vant to the subject of PWD (Table 1). Articles that were not written
in English or did not have full text available were excluded. We
included all relevant papers, regardless of the level of evidence [14].
Although most articles were of low level of evidence, we included
these articles because of the small number of available papers on
the subject of PWD and due to the lack of articles with a higher level
of evidence. Based on this literature review, we developed a clas-
siﬁcation of PWD and an algorithmic approach to PWD after TJA
that may guide clinicians in their decision-making process to select
the appropriate treatment for PWD.Incidence and Relevance
The reported incidence of PWD after TJA varies between 0.2%
and 21% [3e5,8,9,13], with higher incidences after revision TJA [8].
This wide range in incidence is mainly caused by the variation in
deﬁnitions of PWD (Table 1), illustrating the lack of consensus
regarding the deﬁnition of PWD. Moreover, higher awareness re-
sults in higher incidences of PWD, as demonstrated by Maathuis
et al [13] who found a 21% incidence of PWD when protocol-based
surveillance was used to detect wound drainage after TJA.
Wound drainage is usually a noninfectious disturbance in
wound healing of short duration that occurs during the ﬁrst days
after TJA [2], but it may be an early symptom of a (developing) PJI.
Research published between 1973 and 1983 described PWD as one
of the main risk factors for developing a PJI [5,15e19], even though
several researchers could not observe a correlation between PWD
and PJI [20e23]. Contemporary research underscored the adverse
effects of wound complications, such as an increased risk of PJI,
readmission, prolonged hospital stay, reoperations, and higher
healthcare costs [1e4,6e8,12,24].
Regarding the consequences of PWD after total knee arthro-
plasty (TKA), Galat et al [2] found a 6% increased cumulative risk of
PJI in patients who required early surgical treatment for any early
wound healing complication after TKA. Moreover, these patients
had 5.3% risk of major additional surgical intervention (resection
arthroplasty, muscle ﬂaps, or amputation) in the ﬁrst 2 years
following TKA [2]. A different study by Galat et al [25] showed an
increased risk of 10.5% for PJI and 12.3% risk for major reoperation
within 2 years after TKA in patients who required surgical inter-
vention for postoperative hematoma.
Regarding the consequences of PWD after both total hip arthro-
plasty (THA) and TKA, Parvizi et al [26] demonstrated that patients
who developed a PJI weremore likely to have experienced PWD and
hematoma thanpatientswithout PJI (16.8 and12.6 timesmore likely
respectively). Similar results were reported by Saleh et al [7].
Although most studies on wound-related complications after
TJA have focused on the risk of developing PJI, wound-related
complications also predispose patients to worse functionalpatients requiring additional surgery for hematoma after THA.
Adelani et al [9] observed similar worse functional outcome for
patients with wound complications after TKA. Moreover, published
data suggest that patients with PWD after TKA have an increased
risk of residual pain and poor functional outcome, similar to pa-
tients who develop an infectious complication after TKA [9]. Patient
expectation after wound complications following TJA should
therefore be tempered, even if wound complications do not result
in PJI.
Theoretical and Practical Considerations
Wound drainage after TJA can be physiological in the ﬁrst days
after index surgery. However, it is unknownwhen wound drainage
should be perceived as persistent or abnormal. Many other issues
related to wound complications remain unanswered as well, such
as the following: To what extent will wound drainage impair
wound healing and/or offer a retrograde gateway for entry of
pathogens into the joint space? [8] Where does wound drainage
originate? If it originates from deeper layers of the joint, does it
represent an early deep infection or merely normal drainage from
defects in the soft tissues? If it originates from outside the joint,
does it represent normal wound drainage or a draining hematoma
or abscess? [1] All these issues are important for the decision-
making process but remain difﬁcult to clarify.
Deﬁnition of PWD
Literature lacks a proven deﬁnition of PWD in terms of both
duration and amount of drainage. Previous studies used a deﬁnition
of duration of wound drainage varying from 2 to 9 days after index
surgery (Table 1) [3,8]. In 2013, the ﬁrst International Consensus
Meeting (ICM) on PJI deﬁned PWD as >2  2 cm of drainage in the
wound dressing beyond 72 hours after index surgery [27,33]. This
consensus stated that limiting the deﬁnition of PWD to 72 hours
postoperative allows for early intervention that may prevent the
adverse consequences of PWD. However, the deﬁnition of PWD
should be further speciﬁed and evaluated.
Clinical and Serological Signs of a Developing Infection
Clinical signs of wound infection (superﬁcial or deep) include
systemic and local signs. Systemic signs involve fever, chills, and
tachycardia. Local signs include induration, painful skin erythema
(especially around the sutures), warmth, purulent drainage, and
presence of a sinus tract [34]. However, some of these clinical signs
are frequently observed in the ﬁrst days after uncomplicated TJA
surgery as an early physiological response to surgical trauma.
Fever or pyrexia (generally deﬁned as temperature >38.5C/
>101F) is physiological in the ﬁrst 3-5 days after index surgery
[35e45]. In this postoperative phase, additional tests for an un-
derlying infectious cause of fever is unwarranted as it results in
patient discomfort, has minor clinical yield, and is accompanied by
considerable healthcare costs [35,36,39e46]. However, tempera-
tures >39C, particularly if present for multiple days and/or later
than 3-5 days after surgery, require further diagnostic tests [46].
Described blood serology parameters in the diagnosis of PJI are
C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and
white blood cell count (WBC). After uncomplicated TJA surgery, the
CRP level increases rapidly and reaches maximum level (up to 200-
400 mg/L) within 2-3 days, followed by a quick decrease and
normalization to preoperative level in 2-8 weeks after uncompli-
cated TJA, even in patients with rheumatoid arthritis [47e61]. An
Table 1
Overview of Literature Addressing Wound Drainage After Total Joint Arthroplasty.







Duration of Drainage Amount of Drainage
Adelani [9] Retrospective
N ¼ 2221 TKAs
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higher incidence of
mild or greater pain








persists beyond 5-7 d,
spontaneous cessation





N ¼ 5627 THAs
4 >3-4 d after TJA Drainage that has
soaked through the
postoperative dressings
2.0% NPWT was started after
3-4 d of wound
drainage in 109
patients and applied for
2 d. Seventy-six percent
















3 >2 d after TJA Drainage that has
soaked through the
postoperative dressings
2.9% Three hundred patients
with wound drainage
>48 h were treated
with local wound care
and oral antibiotics.
Wound drainage
stopped between 2 and











failure of the ﬁrst
debridement
Lonner [12] Opinion N/A Several days after TJA N/A N/A Wound drainage
beyond several days
after surgery may
increase the risk of
infection. Drainage will
usually stop after 24-
48 h of immobilization.
(continued on next page)
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be resumed once the
wound is stable
Maathuis [13] Retrospective N ¼ 558
TKAs/THAs
3 >5 d after TJA N/A 16.5% Comparison of an
algorithmic approach





(21% vs 11%), but the
number of open
debridements was
lower (17% vs 30%) and
the salvage rate higher
(94% vs 85%)
Patel [4] Retrospective N ¼ 2437
TKAs/THAs
2 >5 d after TJA 2 2 cm area of gauze
covering the wound is
wet or when the ﬂuid is






Each day of wound
drainage after day 5
increased the risk of
wound infection by 42%
following THA (P <




Saleh [7] Prospective N ¼ 2305
TKAs/THAs












>5 d of wound drainage
had 12.7 times more
risk of developing a
prosthetic joint
infection
Surin [5] Retrospective N ¼ 803
THAs









drainage had a 3.2
times higher risk of
developing a prosthetic
joint infection. The risk
was further inﬂuenced
by the character of the
exudate and the use of
prophylactic antibiotics
Vince [1] Review/opinion N/A Limited amount of time N/A N/A Persistent wound
drainage should be
treated by wound care
and immobilization. If
(continued on next page)
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Duration of Drainage Amount of Drainage
drainage does not stop





starts in the late
postoperative phase is a
great concern as it
usually results from a
prosthetic joint
infection
Weiss [8] Retrospective N ¼ 597
TKAs
4 4 consecutive days
beyond day 5 after TJA
2 2 cm area of gauze
covering the wound is
wet or when the ﬂuid is
noted to be originating
from the surgical
wound





average of 12.5 d after
index surgery. Twenty-






N/A, not applicable or not described; THA, total hip arthroplasty; TKA, total knee arthroplasty; TJA, total joint arthroplasty; NPWT, negative pressure wound therapy; BMI, body
mass index.
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if CRP levels increase later than 72 hours after TJA, or remain
elevated beyond 7 days after TJA [52,57e59,61,62].
The WBC and ESR are less appropriate for the diagnosis of PJI in
case of PWD, since the WBC increases only slightly after surgery
and returns to normal within 7 days after index surgery, while the
ESR increases only gradually, with peak level between day 5 and 14
and normalization in 19 days up to 9 months after index surgery
[47,54,55,59e61,63].
An Algorithmic Approach to the Decision-Making Process
In clinical practice, assessment of the origin (intra-articular or
extra-articular) and type of wound drainage (physiologic or infec-
tious secretion) is often difﬁcult. Weiss and Krackow [8] concluded
that wound drainage can offer a pathway where pathogens can
enter the wound and joint, acting as a retrograde pathway for
infection. This implies that PWD should be perceived as potential
imminent PJI, hence justifying a low threshold for early surgical
intervention [1,64]. However, advocating early surgical interven-
tion may result in unnecessary operations, while delaying early
surgical intervention may result in the development of PJI.
An evidence-based algorithmic approach on PWD may ease the
decision-making process in the diagnosis and timing of treatment.
In literature, some authors merely provided general statements on
the evaluation of wound complications [1,2,27]. Only few studies
speciﬁcally addressed PWD [3e8,13] and only one of these studies
described an algorithmic approach [13]. In this study, the algo-
rithmic approachwas compared to an ad hoc approach inwhich the
surgeon decided upon own discretion. Even though the reported
percentage of PWD was 2 times higher in the algorithmic cohort
(21% vs 11%), the number of surgical interventions was lower (17%
vs 30%) and the salvage percentage was higher (94% vs 85%) [13].
This suggests that an algorithmic approach may lead to increased
awareness of PWD and an improved decision-making process with
a lower frequency of surgical interventions and better outcome.Timing of Treatment
The optimal timing of starting nonsurgical or surgical treatment
in patients with PWD remains to be established. Patel et al [4]
stated that each day of PWD beyond day 5 after TJA surgery
increased the risk of wound infection with 42% after THA and 29%
after TKA. Saleh et al found a 12.7 times higher risk of developing PJI
when the wound drained for more than 5 days after THA/TKA
compared to patients with shorter duration of wound drainage.
Based on these ﬁndings, they advised on performing open
debridement in case of hematoma or PWD for more than 7 days
postoperative [7].
More recently, Jaberi et al [3] (deﬁning wound drainage as
persistent when drainage soaked postoperative dressing for more
than2days) showed thatdrainingwounds afterTHAandTKAhealed
uncomplicated within 2-4 days of nonsurgical treatment (wound
care and antimicrobial treatment) in 72% of patients. The remaining
28% underwent open debridement. This was successful in 76% of
patients,while the remaining24%underwent subsequent treatment
including repeated debridement, resection arthroplasty, or sup-
pressive antimicrobial treatment. These authors recommended
early surgery within 7 days after index surgery even though their
successful debridement antibiotic and implant retentions were
performedat ameanof 14days (range4-32days) after index surgery
[3]. Based on these studies, the ICM formulated the statement that
surgical treatment should be performed if wound drainage persists
for longer than 5-7 days after index surgery [27].
Nonsurgical Treatment Strategies
Nonsurgical treatment strategies are usually performed prior to
surgical intervention [27]. Since PWD is associated with an
increased risk of PJI, observation only is highly discouraged
[3,4,7,8]. Acceptable nonsurgical treatment is adequate wound care
by using absorbent dressings and pressure bandages (hand-made
spica for the hip), supplemented by several days of joint
Figure 1. Proposed algorithm for diagnosis and treatment of persistent wound drainage after total joint arthroplasty.
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and braces may impair early rehabilitation, but this outweighs the
potential risk of prolonging the duration of PWD and increasing the
risk of PJI [1,12]. Good results were reported on the use of silver-
impregnated dressings [66] and negative pressure wound therapy
(NPWT) [11,67e69]. However, a Cochrane meta-analysis could not
ﬁnd deﬁnitive evidence for the effectiveness of NPWT [69].
The ICM advised on early analysis and correction of anti-
coagulation, anemia, glucose regulation in diabetic patients, and
malnutrition [27]. One study retrospectively evaluated 11,785
THAs/TKAs and found malnutrition to predispose for failure of
surgical debridement and an increased risk of PJI in patients with
PWD. Therefore, they recommended consultation of a nutritional
physician in order to treat in case of wound drainage persisting
longer than 48 hours [3]. With regard to anticoagulation, Parvizi
et al showed that patients with a mean International Normalized
Ratio higher than 1.5 had an increased risk of developing wound
complications and PJI after THA/TKA. Hence, they stressed the
importance of cautious anticoagulant treatment in order to
prevent formation of a hematoma and subsequent wound
drainage [26].Although antimicrobial treatment during PWD has been
described [3], current consensus discourages antimicrobial treat-
ment due to a lack of evidence on decreasing the risk of PJI [11,12].
Furthermore, it may confound culture results thus impairing the
diagnosis of an early PJI. And ﬁnally, concerns about the increase in
antimicrobial resistance cannot be ignored [34].
Surgical Treatment Strategies
Most publications advocate early surgical treatment in case
wound drainage persists despite a period of adequate nonsurgical
treatment [1,3,10,27]. Surgical treatment typically consists of open
deep debridement and thorough irrigation, using 6-9 L of saline
administered by low-pressure pulsatile jet lavage [70]. Optionally,
diluted povidone-iodine or chlorhexidine gluconate can be used to
irrigate the joint cavity [71e73]. However, it should be recognized
that these recommendations on irrigation are derived from litera-
ture on primary TJA and trauma surgery, mostly from animal and
basic science studies.
Whenever possible, modular components should be exchanged
as it offers a better potential for thorough debridement and
Table 2
Proposed Classiﬁcation of Persistent Wound Drainage After Total Joint Arthroplasty.
Category Description
1 (Limited) A stripe of blood in the wound dressing in the line of the
wound or less than 2  2 cm in sizea
2 (Moderate) More than 2  2 cm drainage in absorbent gauze or
dressing but without the need for change in the wound
dressing (ie, dressing is not soaked)
3 (Excessive) One dressing change per day due to soaked absorbent
gauze or dressing
4 (Massive) Two or more daily dressing changes due to soaked
absorbent gauzes or dressings
a According to the 2013 International Consensus Meeting on Periprosthetic Joint
Infection [28,33].
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component exchange is advised because the polyethylene compo-
nent (acetabular liner or tibial inlay) may be colonized by patho-
gens [8]. The soft tissue should be meticulously closed in a
multilayer fashion [12,27]. NPWT is a plausible alternative when
wound closure is not possible [69]. In these cases, consultation of a
plastic surgeon is recommended.
Administration of prophylactic antimicrobial treatment is
advised prior to incision [34,74]. Various deep tissue samples for
bacterial cultures are obtained, preferably 5 samples to increase
pathogen detection. Each tissue sample is obtained using a clean
instrument to avoid contamination. Tissue swabs are not advised
[34]. Tissue samples should be cultured up to 14 days and antimi-
crobial treatment is continued until culture results are deﬁnitive
[34]. In case of positive culture results, targeted antimicrobial
treatment should be continued in consultation with an infectious
disease specialist, usually 6-12 weeks. Jaberi et al found positive
deep periprosthetic tissue cultures in 34% (28 of 83 cases) after
surgical treatment for PWD after THA/TKA. Cultures were more
often positive in the failure group (17 of 20, 85%) compared to the
success group (11 of 63, 17%) [3]. Weiss and Krackow [8], reporting
PWD in 8 of 597 primary TKAs, showed that 25% (2 of 8 cases) had
positive cultures after surgical debridement at a mean of 12.5 days
after surgery (range 8-18 days). However, issues can be raised on
the statistical power of this study cohort.
Summary
The reported incidence of PWD after TJA varies between 0.2%
and 21%, with higher incidences after revision TJA. This wide range
in incidence is mainly caused by the variation in deﬁnitions of PWD.
The ICM formulated a deﬁnition that deﬁnes PWD as >2  2 cm for
longer than 72 hours, but this deﬁnition should be further speciﬁed
and validated.
Clinical signs of infection and blood serology can be helpful in
diagnosing PJI in case of PWD, although some clinical signs can be a
normal physiological response in the ﬁrst days after TJA. An in-
crease in CRP later than 72 hours after index surgery or persistent
elevated levels of CRP beyond 7 days can indicate development of
an infectious complication.
Nonsurgical treatment of PWD generally involves absorbent
dressings, pressure bandages, and temporary joint immobilization.
Present consensus discourages the use of antimicrobial treatment.
Nutritional consultation and correction of anticoagulation and
metabolic imbalances should be considered.
Surgical treatment should be performed when wound drainage
persists for more than 5-7 days after index procedure despite
adequate nonsurgical treatment. Nonetheless, establishing this
time frame needs validation in future research. Surgical treatment
should include thorough open debridement and irrigation,
obtaining tissue samples (cultured up to 14 days) and exchange of
modular components. Empirical broad spectrum antimicrobial
treatment is administered in consultation with an infectious dis-
eases specialist.
Proposed Algorithm
Based on this literature review, the authors developed an algo-
rithm to facilitate the decision-making process of PWD after TJA
(Fig. 1). Although we aimed to differentiate between PWD in THA
and TKA in this algorithm, we did not ﬁnd enough scientiﬁc evi-
dence tomake this distinction. In addition to the algorithm, we also
propose a classiﬁcation of PWD that divides wound drainage into 4
categories based on the amount of drainage (Table 2). As this
classiﬁcation is merged into the algorithm, the amount of drainageis combined with the duration of drainage (Fig. 1), in which larger
amounts of wound drainage are tolerated for a shorter period.
Hopefully, this algorithm offers the orthopedic surgeon a practical
clinical guideline by ﬁnding the right balance between over-
treatment and undertreatment, weighing risks and beneﬁts.
Currently, a multicenter randomized controlled trial on the optimal
treatment of PWD after TJA is being conducted to examine the
validity and applicability of such a classiﬁcation and algorithm in
daily clinical practice [75].Conclusion
This review summarizes the available literature addressing
several issues in the ﬁeld of PWD after TJA. There are limited sci-
entiﬁc data on PWD and absence of an evidence-based guideline
regarding diagnosis and treatment, partially caused by the lack of a
universally accepted deﬁnition. We developed a classiﬁcation of
PWD and an algorithmic approach for the management of PWD
after TJA to offer the orthopedic surgeon a practical guideline for
daily clinical practice.References
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